Pure Global
NCT06415929

Etude rétrospective Monocentrique MATRIX

Single-center Retrospective Study Evaluating the Characteristics, Quality of Life and Satisfaction of Patients Undergoing Nail Resection With Dermal Matrix and Skin Graft Reconstruction at Nice University Hospital.
Centre Hospitalier Universitaire de Nice·ClinicalTrials.govCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Melanoma
Study type
Observational
Sponsor & location
Primary sponsor
Centre Hospitalier Universitaire de Nice
Location
Nice, France
Timeline & enrollment
Phase
N/A
Start date
Mar 20, 2024
End date
Apr 15, 2024
Enrollment
15 participants
Primary outcome

Quality of life evaluation

Summary

Monocentric retrospective study.Analysis of a case series of patients who underwent nail
 resection with dermal matrix and skin graft reconstruction in the setting of nail bed
 malignancy.
 
 Objective: To assess patients' quality of life and satisfaction with the function and
 aesthetics of dermal matrix and skin graft reconstruction of the nail apparatus.
 
 Monocentric retrospective study.Analysis of a case series of patients who underwent nail
 resection with dermal matrix and skin graft reconstruction in the setting of nail bed
 malignancy.
 
 Objective: To assess patients' quality of life and satisfaction with the function and
 aesthetics of dermal matrix and skin graft reconstruction of the nail apparatus.
 
 

ICD-10 classifications
Malignant melanoma of skinMelanoma in situ, unspecifiedMelanoma in situMelanoma and other malignant neoplasms of skinMalignant neoplasm: Malignant melanoma of skin, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06415929
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06415929 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Universitaire de Nice and is currently Completed. The study focuses on Melanoma. Target enrollment is 15 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.